Tech Center 3700 • Art Units: 3724 3785 3791 3796
This examiner grants 56% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18680439 | FLUID CONTROL DEVICES AND METHODS OF USING THE SAME | Final Rejection | Magnolia Medical Technologies, Inc. |
| 18680377 | FLUID CONTROL DEVICES AND METHODS OF USING THE SAME | Final Rejection | Magnolia Medical Technologies, Inc. |
| 18680331 | FLUID CONTROL DEVICES AND METHODS OF USING THE SAME | Final Rejection | Magnolia Medical Technologies, Inc. |
| 18680348 | FLUID CONTROL DEVICES AND METHODS OF USING THE SAME | Final Rejection | Magnolia Medical Technologies, Inc. |
| 18407010 | FLUID CONTROL DEVICES AND METHODS OF USING THE SAME | Non-Final OA | Magnolia Medical Technologies, Inc. |
| 18154045 | APPARATUS AND COMPUTER-IMPLEMENTED METHOD FOR PROVIDING INFORMATION ABOUT A USER'S BRAIN RESOURCES, NON-TRANSITORY MACHINE-READABLE MEDIUM AND PROGRAM | Non-Final OA | Sony Group Corporation |
| 18257473 | Calibration of Positions of EEG Electrodes on a Subject | Non-Final OA | Telefonaktiebolaget LM Ericsson (publ) |
| 18486030 | FUNCTIONAL THRESHOLD POWER PREDICTION USING MACHINE LEARNING | Non-Final OA | Apple Inc. |
| 18223785 | SYSTEMS AND METHODS OF OPTICAL NEURAL STIMULATION FOR INTRAOPERATIVE NERVE MONITORING | Non-Final OA | VANDERBILT UNIVERSITY |
| 18153972 | METHODS AND SYSTEMS FOR NEUROFEEDBACK TRAINING | Final Rejection | Synchron Australia Pty Limited |
| 18347667 | PHRENIC NERVE INTEGRITY AND RAMPED-UP BURST | Non-Final OA | Covidien LP |
| 18020045 | NEUROMUSCULAR CHARACTERISATION METHOD AND ASSOCIATED MEASURING BENCH | Non-Final OA | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE |
| 18344702 | System and Method of Assessing a Patient's Visual Function | Non-Final OA | Cadwell Laboratories, Inc. |
| 17485316 | Monitoring Device, System, and Method for Unrestrained Neural Signal Analysis | Final Rejection | Korea Institute of Science and Technology |
| 17976970 | OCULAR IMPEDANCE-BASED SYSTEM FOR BRAIN HEALTH MONITORING | Final Rejection | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 18691901 | MEASUREMENT DEVICE | Non-Final OA | Nippon Telegraph and Telephone Corporation |
| 18276827 | SYMPTOM DETERMINATION APPARATUS AND STORAGE MEDIUM FOR DETERMINING SYMPTOM | Final Rejection | KEIO UNIVERSITY |
| 18270671 | MACHINE SEGMENTATION OF SENSOR MEASUREMENTS AND DERIVATIVES IN VIRTUAL MOTOR EXAMS | Non-Final OA | Verily Life Sciences LLC |
| 17884744 | METHOD FOR PREPARING AN AUDIOGRAM OF A TEST SUBJECT BY USE OF A HEARING INSTRUMENT | Non-Final OA | Sivantos Pte. Ltd. |
| 18572452 | A METHOD AND SYSTEM FOR DETERMINING A PERFUSION METRIC USING DEOXYHEMOGLOBIN AS A CONTRAST AGENT | Non-Final OA | THORNHILL SCIENTIFIC INC |
| 17083078 | SYSTEMS AND METHODS FOR PROCESSING SONIFIED BRAIN SIGNALS | Final Rejection | CeriBell, Inc. |
| 18041602 | IMPLANT, MONITORING SYSTEM FOR ORGANISM, AND MANAGEMENT SYSTEM FOR ORGANISM | Non-Final OA | ATONARP INC. |
| 17284842 | ADSORPTION AND BINDING OF PLASMA MOLECULES AND PARTICLES TO CARBON | Non-Final OA | IMMUTRIX THERAPEUTICS, INC. |
| 18392197 | Method And System For Non-Invasive Management And Monitoring Of Intercranial Pressure And A Device For Measuring Of A Skull Volumetric Variation | Non-Final OA | BRAINCARE DESENVOLVIMENTO E INOVACÃO TECNOLÓGICA S.A. |
| 18199048 | METHOD OF EVALUATING AGING LEVEL OF A HUMAN THROUGH MEASURING VASCULAR STRUGGLE IN AN AGING HUMAN TISSUE | Final Rejection | NuLiv Science USA, Inc. |
| 18230209 | ELECTRONIC DEVICE | Final Rejection | ONKYO CORPORATION |
| 18302042 | AMBULATORY MEDICAMENT PUMP WITH AUTOMATED SUPPORT CONTACT | Non-Final OA | BETA BIONICS, INC. |
| 18256635 | MEASURING DEVICE FOR NON-INVASIVELY DETECTING THE INTRACRANIAL PRESSURE OF A PATIENT, AND CORRESPONDING METHOD | Non-Final OA | iNDTact GmBH |
| 18037989 | SYSTEM AND METHOD FOR ASSESSING NEUROMUSCULAR DISEASE | Final Rejection | MOVEMED LIMITED |
| 17804407 | NON-AUDITORY NEUROSTIMULATION AND METHODS FOR ANESTHESIA RECOVERY | Non-Final OA | BrainFM, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy